Search Results 2881-2890 of 15068 for Giardia+lamblia

1. Primary Cell Lines Derived from the Human Gall Bladder for the Purpose of Gene and Cell Therapy for Metabolic Liver Disorders - Mayo Clinic

   About this study. This research study will help us to improve our understanding of normal liver and gallbladder function. Additionally, this research study ...

2. Translational Cardiovascular Disease Research Laboratory - Mayo Clinic Research

   Translational Cardiovascular Disease Research Lab of DeLisa Fairweather at Mayo Clinic: Sex differences, myocarditis, biomarkers, inflammatory disease.

3. Safety and Immune Response of the COVID 19 Vaccine in Patients with Inflammatory Bowel Disease - Mayo Clinic

   About this study. This will be a prospective study of patients with IBD at Mayo Clinic initially in Jacksonville with possible subsequent extension to other ...

4. Pediatric MSC-AFP Sub-study for Crohn's Fistula - Mayo Clinic

   The purpose of this study is to determine the safety of using an autologous mesenchymal stromal cell (MSC) coated fistula plug in people with fistulizing ...

5. How to optimize referral timing for severe liver disease - Mayo Clinic

   Timing referral of these patients to discuss transplant or other options is challenging. Disease status can turn quickly, and it's important to not refer ...

6. Myeloma, Amyloidosis, Dysproteinemia Group - Overview - Mayo Clinic

   Macroglobulinemia; Monoclonal gammopathy-associated conditions including C1-esterase inhibitor deficiency, cryoglobulinemia, osteosclerotic myeloma, peripheral ...

7. Patient Stories - David A. Miller, M.D. - Mayo Clinic

   Their crucial work saves lives every day. Let Mayo Clinic researchers know they're appreciated with a quick message.

8. Gastrointestinal Barrier Function Laboratory - Mayo Clinic Research

   Gastrointestinal Barrier Function Lab of Dr. Madhu Grover at Mayo Clinic: Studying postinfectious IBS, intestinal permeability, gastroparesis and more.

9. Education and Training - Gastrointestinal Barrier Function Laboratory - Mayo Clinic Research

   Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...

10. Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy - Mayo Clinic

    Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy.